查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1991354

全球生命科学分析市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Life Science Analytics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计生命科学分析市场将从 2025 年的 155.3 亿美元成长到 2034 年的 310.7 亿美元，2026 年至 2034 年的复合年增长率为 8.01%。

全球生命科学分析市场正快速成长，这主要得益于数据分析在药物研发、医疗保健和生技领域的日益普及。生命科学分析涉及分析复杂的生物和医学数据，以支援药物发现、临床试验和医疗保健管理中的决策。数位健康数据的日益丰富正在显着扩大分析技术在生命科学领域的作用。

多种因素促成了这一市场的成长。製药公司正利用先进的分析技术加速药物研发并简化临床试验流程。医疗机构也正在采用资料分析来改善患者疗效并优化治疗方案。此外，人工智慧 (AI) 和机器学习的融合也提高了处理大规模生物数据集的能力。

随着数位转型在整个医疗产业的推进，生命科学分析市场前景广阔。资料管理技术的进步和研发投入的增加有望推动创新。随着各机构越来越依赖数据驱动的洞察，生命科学分析将在塑造医疗保健和生物技术的未来方面发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球生命科学分析市场：依组件划分

  • 市场分析、洞察与预测
  • 软体
  • 服务

第五章：全球生命科学分析市场：按类型划分

  • 市场分析、洞察与预测
  • 报告
  • 说明的
  • 预测分析
  • 指示

第六章 全球生命科学分析市场：依应用划分

  • 市场分析、洞察与预测
  • 研究与开发
  • 销售和行销支持
  • 监理合规
  • 供应链分析
  • 药物安全监测

第七章 全球生命科学分析市场：以交付方式划分

  • 市场分析、洞察与预测
  • 一经请求
  • 现场

第八章 全球生命科学分析市场：依最终用途划分

  • 市场分析、洞察与预测
  • 医疗设备
  • 製药
  • 生物技术
  • 基因组学
  • 其他的

第九章 全球生命科学分析市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十一章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Oracle
    • IQVIA
    • SAS Institute Inc
    • Cognizant
    • IBM
    • Accenture
    • Take Solutions Limited
    • Wipro Limited
    • Veradigm
    • Optum
    • Veeva Systems
    • Axtria
    • Komoda Health Inc
    • Elsevier
简介目录
Product Code: VMR11213489

The Life Science Analytics Market size is expected to reach USD 31.07 Billion in 2034 from USD 15.53 Billion (2025) growing at a CAGR of 8.01% during 2026-2034.

The global life science analytics market has grown rapidly due to the increasing use of data analytics in pharmaceutical research, healthcare, and biotechnology. Life science analytics involves analyzing complex biological and healthcare data to support decision-making in drug development, clinical trials, and healthcare management. The growing availability of digital health data has significantly expanded the role of analytics in the life sciences sector.

Several drivers are contributing to the growth of this market. Pharmaceutical companies are using advanced analytics to accelerate drug discovery and improve clinical trial efficiency. Healthcare organizations are also adopting data analytics to enhance patient outcomes and optimize treatment strategies. Additionally, the integration of artificial intelligence and machine learning has improved the ability to process large biological datasets.

The future of the life science analytics market looks promising as digital transformation continues across the healthcare industry. Advances in data management technologies and increased investment in research are expected to drive innovation. As organizations rely more heavily on data-driven insights, life science analytics will play a crucial role in shaping the future of healthcare and biotechnology.

MARKET SEGMENTATION

By Component

  • Software
  • Services

By Type

  • Reporting
  • Descriptive
  • Predictive
  • Prescriptive

By Application

  • Research And Development
  • Sales And Marketing Support
  • Regulatory Compliance
  • Supply Chain Analytics
  • Pharmacovigilance

By Delivery

  • On-Demand
  • On-Premise

By End Use

  • Medical Devices
  • Pharmaceutical
  • Biotechnology
  • Genomics
  • Others

COMPANIES PROFILED

  • Oracle, IQVIA, SAS Institute Inc, Cognizant, IBM, Accenture, Take Solutions Limited, Wipro Limited, Veradigm, Optum, Veeva Systems, Axtria, Komoda Health Inc, Elsevier
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Descriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Predictive Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Prescriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Research And Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Sales And Marketing Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Regulatory Compliance Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Supply Chain Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Pharmacovigilance Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY DELIVERY 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Delivery
  • 7.2. On-Demand Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Pharmaceutical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Component
    • 9.2.2 By Type
    • 9.2.3 By Application
    • 9.2.4 By Delivery
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Component
    • 9.3.2 By Type
    • 9.3.3 By Application
    • 9.3.4 By Delivery
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Component
    • 9.4.2 By Type
    • 9.4.3 By Application
    • 9.4.4 By Delivery
    • 9.4.5 By End Use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Component
    • 9.5.2 By Type
    • 9.5.3 By Application
    • 9.5.4 By Delivery
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Component
    • 9.6.2 By Type
    • 9.6.3 By Application
    • 9.6.4 By Delivery
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL LIFE SCIENCE ANALYTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Oracle
    • 11.2.2 IQVIA
    • 11.2.3 SAS Institute Inc
    • 11.2.4 Cognizant
    • 11.2.5 IBM
    • 11.2.6 Accenture
    • 11.2.7 Take Solutions Limited
    • 11.2.8 Wipro Limited
    • 11.2.9 Veradigm
    • 11.2.10 Optum
    • 11.2.11 Veeva Systems
    • 11.2.12 Axtria
    • 11.2.13 Komoda Health Inc
    • 11.2.14 Elsevier